Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

1.92
Delayed Data
As of Feb 20
 -0.11 / -5.42%
Today’s Change
1.68
Today|||52-Week Range
6.12
-13.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-62.1M-95.7M-117.5M-198.6M
 
 
 
 
 
Depreciation56.0K120.0K163.0K233.0K
 
 
 
 
 
Total Other Cash Flow4.5M3.9M14.6M62.0M
 
 
 
 
 
Funds From Operations-57.5M-91.7M-102.7M-136.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-4.9M-2.6M-1.7M-6.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-52.6M-89.1M-101.0M-129.8M
 
 
 
 
 
 
InvestingIncrease In Investments-30.0M0.00-200.0K--
 
 
 
Decrease In Investments0.000.000.0050.1M
 
 
Capital Expenditures-615.0K-173.0K-50.0K-297.0K
 
 
 
 
 
Other Investing - Uses-270.0K0.000.000.00
 
 
Other Investing - Sources0.00455.0K0.000.00
 
 
Net Cash Flow Investing-30.9M282.0K-250.0K49.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.00187.3M0.00-711.0K
 
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale89.2M33.1M16.4M101.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.00-3.2M0.000.00
 
 
Cash Dividends Paid - Total0.00-3.2M0.000.00
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing89.2M217.1M16.4M100.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash5.7M128.3M-84.8M20.7M